WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 561759
CAS#: 194656-75-2 (HCl)
Description: ABH Hydrochloride is an arginase inhibitor, enhancing both male and female sexual arousal responses.
MedKoo Cat#: 561759
Name: ABH Hydrochloride
CAS#: 194656-75-2 (HCl)
Chemical Formula: C6H15BClNO4
Molecular Weight: 211.44
Elemental Analysis: C, 34.08; H, 7.15; B, 5.11; Cl, 16.77; N, 6.62; O, 30.27
Synonym: ABH Hydrochloride; ABH HCl; 6-borono-L-norleucine;
IUPAC/Chemical Name: 2(S)-Amino-6-boronohexanoic acid hydrochloride
InChi Key: XCUVEZUCSHVMRK-JEDNCBNOSA-N
InChi Code: InChI=1S/C6H14BNO4.ClH/c8-5(6(9)10)3-1-2-4-7(11)12;/h5,11-12H,1-4,8H2,(H,9,10);1H/t5-;/m0./s1
SMILES Code: O=C(O)[C@@H](N)CCCCB(O)O.[H]Cl
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
The following data is based on the product molecular weight 211.44 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1: Ali OI, Ismail NS, Elgohary RM. Validated derivative and ratio derivative spectrophotometric methods for the simultaneous determination of levocetirizine dihydrochloride and ambroxol hydrochloride in pharmaceutical dosage form. Spectrochim Acta A Mol Biomol Spectrosc. 2016 Jan 15;153:605-11. doi: 10.1016/j.saa.2015.09.014. Epub 2015 Sep 25. PubMed PMID: 26439526.
2: Jakse G, Hofstädter F. Mechanisms of action of intravesical treatment. Effect on the ABH surface antigens of urothelial cells. Cancer Chemother Pharmacol. 1983;11 Suppl:S74-8. PubMed PMID: 6640839.
3: Jakse G, Hofstädter F. ABH antigenicity of in situ carcinoma of the urinary bladder during intracavity treatment with doxorubicin hydrochloride. Urol Res. 1981;9(3):153-6. PubMed PMID: 7257030.